{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:01:59Z","timestamp":1788321719192,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.nano.2016.11.019","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T02:16:03Z","timestamp":1481508963000},"page":"921-932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles"],"prefix":"10.1016","volume":"13","author":[{"given":"Ahlam A.","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cian M.","family":"McCrudden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"McCaffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Kissenpfennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan F.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1254-3745","authenticated-orcid":false,"given":"Helen O.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.nano.2016.11.019_bb0005","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrc1973","article-title":"How will HPV vaccines affect cervical cancer?","volume":"6","author":"Roden","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.nano.2016.11.019_bb0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.coi.2010.11.009","article-title":"Prevention of cancer by prophylactic human papillomavirus vaccines","volume":"23","author":"Kwak","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"33","key":"10.1016\/j.nano.2016.11.019_bb0015","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1016\/j.vaccine.2010.06.018","article-title":"Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine","volume":"28","author":"Dauner","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.nano.2016.11.019_bb0020","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1309\/AJCPCU0HBFFFGDTV","article-title":"HPV vaccine protein L1 predicts disease outcome of high-risk HPV+ early squamous dysplastic lesions","volume":"132","author":"Griesser","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.nano.2016.11.019_bb0025","series-title":"Therapeutic human papillomavirus vaccines: current clinical trials and future directions","author":"Hung","year":"2008"},{"issue":"4","key":"10.1016\/j.nano.2016.11.019_bb0030","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"issue":"21","key":"10.1016\/j.nano.2016.11.019_bb0035","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","article-title":"Mechanisms of human papillomavirus-induced oncogenesis","volume":"78","author":"Munger","year":"2004","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.nano.2016.11.019_bb0040","doi-asserted-by":"crossref","first-page":"e108892","DOI":"10.1371\/journal.pone.0108892","article-title":"Fusion of CTLA-4 with HPV16 E7 and E6 enhanced the potency of therapeutic HPV DNA","volume":"9","author":"Gan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2016.11.019_bb0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-immunol-031210-101308","article-title":"Prevention and treatment of papillomavirus-related cancers through immunization","volume":"29","author":"Frazer","year":"2011","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"10.1016\/j.nano.2016.11.019_bb0050","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S1470-2045(14)71179-9","article-title":"Next generation prophylactic human papillomavirus vaccines","volume":"16","author":"Schiller","year":"2015","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.nano.2016.11.019_bb0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1155\/2007\/245146","article-title":"Therapeutic vaccination for HPV induced cervical cancers. Dis","volume":"23","author":"Brinkman","year":"2007","journal-title":"Markers"},{"issue":"5\u20136","key":"10.1016\/j.nano.2016.11.019_bb0060","first-page":"331","article-title":"Therapeutic human papillomavirus vaccination. Public.Health","volume":"12","author":"Albers","year":"2009","journal-title":"Genomics"},{"issue":"19","key":"10.1016\/j.nano.2016.11.019_bb0065","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","article-title":"Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia","volume":"361","author":"Kenter","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.nano.2016.11.019_bb0070","doi-asserted-by":"crossref","first-page":"e23803","DOI":"10.4161\/onci.23803","article-title":"Trial watch: DNA vaccines for cancer therapy","volume":"2","author":"Senovilla","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.nano.2016.11.019_bb0075","series-title":"Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer","author":"Morrow","year":"2013"},{"issue":"6","key":"10.1016\/j.nano.2016.11.019_bb0080","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/emm.2007.74","article-title":"DNA vaccines for cervical cancer: from bench to bedside","volume":"39","author":"Hung","year":"2007","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.nano.2016.11.019_bb0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/viro.2001.1321","article-title":"Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination","volume":"294","author":"Michel","year":"2002","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.nano.2016.11.019_bb0090","doi-asserted-by":"crossref","first-page":"e1026531","DOI":"10.1080\/2162402X.2015.1026531","article-title":"Trial watch: naked and vectored DNA-based anticancer vaccines","volume":"4","author":"Bloy","year":"2015","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.nano.2016.11.019_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-014-0069-z","article-title":"Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems","volume":"21","author":"Tahamtan","year":"2014","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.nano.2016.11.019_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-015-0025-y","article-title":"Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination","volume":"5","author":"Yang","year":"2015","journal-title":"Cell Biosci"},{"issue":"1","key":"10.1016\/j.nano.2016.11.019_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12645-015-0010-5","article-title":"DNA vaccination for prostate cancer: key concepts and considerations","volume":"6","author":"Cole","year":"2015","journal-title":"Cancer Nanotechnol"},{"issue":"3","key":"10.1016\/j.nano.2016.11.019_bb0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.coi.2010.04.002","article-title":"Designing CD8 T cell vaccines: it's not rocket science (yet)","volume":"22","author":"Yewdell","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.nano.2016.11.019_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2014.06.048","article-title":"Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery","volume":"189","author":"McCarthy","year":"2014","journal-title":"J Control Release"},{"issue":"19","key":"10.1016\/j.nano.2016.11.019_bb0120","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.2217\/nnm.15.115","article-title":"RALA-mediated delivery of FKBPL nucleic acid therapeutics","volume":"10","author":"Bennett","year":"2015","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.nano.2016.11.019_bb0125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s13346-015-0243-1","article-title":"Microneedles: an innovative platform for gene delivery","volume":"5","author":"McCaffrey","year":"2015","journal-title":"Drug Deliv Transl Res"},{"issue":"11","key":"10.1016\/j.nano.2016.11.019_bb0130","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1517\/17425247.2014.938635","article-title":"The role of microneedles for drug and vaccine delivery","volume":"11","author":"Quinn","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"10.1016\/j.nano.2016.11.019_bb0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/jphp.12248","article-title":"Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination","volume":"67","author":"McCrudden","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nano.2016.11.019_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2016.02.023","article-title":"Transcending epithelial and intracellular biological barriers; a prototype DNA delivery device","author":"McCaffrey","year":"2016","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.nano.2016.11.019_bb0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test method for microneedle insertion studies","volume":"472","author":"Larra\u00f1eta","year":"2014","journal-title":"Int J Pharm"},{"issue":"9","key":"10.1016\/j.nano.2016.11.019_bb0150","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1166\/jbn.2014.1981","article-title":"Nanoparticles for DNA vaccine delivery","volume":"10","author":"Shah","year":"2014","journal-title":"J Biomed Nanotechnol"},{"issue":"11","key":"10.1016\/j.nano.2016.11.019_bb0155","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1080\/21645515.2016.1171440","article-title":"The success of microneedle-mediated vaccine delivery into skin","volume":"12","author":"Marshall","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.nano.2016.11.019_bb0160","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/adma.200701205","article-title":"Minimally invasive protein delivery with rapidly dissolving polymer microneedles","volume":"20","author":"Sullivan","year":"2008","journal-title":"Adv Mater"},{"issue":"2","key":"10.1016\/j.nano.2016.11.019_bb0165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejpb.2014.05.003","article-title":"Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice","volume":"88","author":"van der Maaden","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.nano.2016.11.019_bb0170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jconrel.2012.04.005","article-title":"Microneedle delivery of plasmid DNA to living human skin: formulation coating, skin insertion and gene expression","volume":"160","author":"Pearton","year":"2012","journal-title":"J Control Release"},{"issue":"8","key":"10.1016\/j.nano.2016.11.019_bb0175","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nm.2182","article-title":"Dissolving polymer microneedle patches for influenza vaccination","volume":"16","author":"Sullivan","year":"2010","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.nano.2016.11.019_bb0180","doi-asserted-by":"crossref","first-page":"e13460","DOI":"10.1371\/journal.pone.0013460","article-title":"Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model","volume":"5","author":"Corbett","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2016.11.019_bb0185","first-page":"3071","article-title":"Critical evaluation of biodegradable polymers used in nanodrugs","volume":"8","author":"Marin","year":"2013","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"10.1016\/j.nano.2016.11.019_bb0190","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jbm.b.30971","article-title":"Sustained release of complexed and naked DNA from polymer films","volume":"85","author":"Ramgopal","year":"2008","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"3","key":"10.1016\/j.nano.2016.11.019_bb0195","doi-asserted-by":"crossref","first-page":"e0120797","DOI":"10.1371\/journal.pone.0120797","article-title":"Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles","volume":"10","author":"Kines","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.nano.2016.11.019_bb0200","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.gt.3300628","article-title":"Superiority of the ear pinna over muscle tissue as site for DNA vaccination","volume":"5","author":"F\u00f6rg","year":"1998","journal-title":"Gene Ther"},{"issue":"13","key":"10.1016\/j.nano.2016.11.019_bb0205","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.gt.3301220","article-title":"Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine","volume":"7","author":"Schirrmacher","year":"2000","journal-title":"Gene Ther"},{"issue":"5","key":"10.1016\/j.nano.2016.11.019_bb0210","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.vaccine.2004.07.010","article-title":"Plasmid encoding papillomavirus type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection","volume":"23","author":"Cheung","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.nano.2016.11.019_bb0215","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1021\/nn304235j","article-title":"Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D, L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses","volume":"7","author":"Zaric","year":"2013","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.nano.2016.11.019_bb0220","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1039\/C4PY01394H","article-title":"Microneedle-assisted dendritic cell-targeted nanoparticles for transcutaneous DNA immunization","volume":"6","author":"Hu","year":"2015","journal-title":"Polym Chem"},{"issue":"10","key":"10.1016\/j.nano.2016.11.019_bb0225","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1158\/0008-5472.CAN-08-3141","article-title":"Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors","volume":"69","author":"Sharma","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.nano.2016.11.019_bb0230","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.vaccine.2015.11.062","article-title":"Prime-boost vaccine strategy against viral infections: mechanisms and benefits","volume":"34","author":"Kardani","year":"2016","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.nano.2016.11.019_bb0235","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1016\/j.vaccine.2008.03.082","article-title":"Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies","volume":"26","author":"Bolhassani","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.nano.2016.11.019_bb0240","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/vaccines2040785","article-title":"DNA vaccines: recent developments and the future","volume":"2","author":"Wahren","year":"2014","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.nano.2016.11.019_bb0245","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4161\/hv.4.6.6179","article-title":"Immunogenicity of DNA vaccines in humans: it takes two to tango","volume":"4","author":"Lu","year":"2008","journal-title":"Hum Vaccin"},{"issue":"10","key":"10.1016\/j.nano.2016.11.019_bb0250","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet"}],"updated-by":[{"DOI":"10.1016\/j.nano.2026.102932","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000}},{"DOI":"10.1016\/j.nano.2026.102932","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963416302155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963416302155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T17:28:27Z","timestamp":1699118907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963416302155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1549963416302155"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2016.11.019","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2016.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}